γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention123

https://doi.org/10.1093/ajcn/74.6.714Get rights and content
Under an Elsevier user license
open archive

ABSTRACT

γ-Tocopherol is the major form of vitamin E in many plant seeds and in the US diet, but has drawn little attention compared with α-tocopherol, the predominant form of vitamin E in tissues and the primary form in supplements. However, recent studies indicate that γ-tocopherol may be important to human health and that it possesses unique features that distinguish it from α-tocopherol. γ-Tocopherol appears to be a more effective trap for lipophilic electrophiles than is α-tocopherol. γ-Tocopherol is well absorbed and accumulates to a significant degree in some human tissues; it is metabolized, however, largely to 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman (γ-CEHC), which is mainly excreted in the urine. γ-CEHC, but not the corresponding metabolite derived from α-tocopherol, has natriuretic activity that may be of physiologic importance. Both γ-tocopherol and γ-CEHC, but not α-tocopherol, inhibit cyclooxygenase activity and, thus, possess antiinflammatory properties. Some human and animal studies indicate that plasma concentrations of γ-tocopherol are inversely associated with the incidence of cardiovascular disease and prostate cancer. These distinguishing features of γ-tocopherol and its metabolite suggest that γ-tocopherol may contribute significantly to human health in ways not recognized previously. This possibility should be further evaluated, especially considering that high doses of α-tocopherol deplete plasma and tissue γ-tocopherol, in contrast with supplementation with γ-tocopherol, which increases both. We review current information on the bioavailability, metabolism, chemistry, and nonantioxidant activities of γ-tocopherol and epidemiologic data concerning the relation between γ-tocopherol and cardiovascular disease and cancer.

KEY WORDS

γ-Tocopherol
α-tocopherol
bioavailability
metabolism
electrophile trap
antiinflammatory activity
cardiovascular disease
cancer
review

Cited by (0)

1

From the University of California, the Department of Molecular and Cell Biology, Berkeley; the Children’s Hospital Oakland Research Institute, Oakland, CA; and the Institute for Infectious Diseases, University of Berne, Berne, Switzerland.

2

Supported by a Postdoctoral Fellowship from the American Heart Association–Western Affiliates (grant 98-24 to QJ); the Swiss National Science Foundation (grant 31-52702 to SC); the Wheeler Fund for the Biological Sciences at the University of California, Berkeley; the Department of Energy (grant DE-FG03-00ER62943); and the National Institute of Environmental Sciences Center (grant ES01896 to BNA).

3

Address reprint requests to BN Ames, Children’s Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609-1673. E-mail: [email protected].